Cargando…

Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol

INTRODUCTION: No randomised controlled trial (RCT) has examined the efficacy of cotrimoxazole (CTX) prophylaxis in HIV-exposed uninfected (HEU) infants during the breastfeeding period, in this new era of effective prevention of mother-to-child transmission (PMTCT) prophylaxis. The efficacy of CTX pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coutsoudis, Anna, Daniels, Brodie, Moodley-Govender, Eshia, Ngomane, Noluthando, Zako, Linda, Spooner, Elizabeth, Kiepiela, Photini, Reddy, Shabashini, Kuhn, Louise, Ramjee, Gita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947798/ https://www.ncbi.nlm.nih.gov/pubmed/27406638 http://dx.doi.org/10.1136/bmjopen-2015-010656

Ejemplares similares

PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa
por: Skhosana, Mandisa, et al.
Publicado: (2016)

Assessment of the Impact of Rapid Point-of-Care CD4 Testing in Primary Healthcare Clinic Settings: A Survey Study of Client and Provider Perspectives
por: Reddy, Shabashini, et al.
Publicado: (2020)

Point-of-care CD4 testing: Differentiated care for the most vulnerable
por: Spooner, Elizabeth, et al.
Publicado: (2022)

Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
por: D’Souza, Alaric W, et al.
Publicado: (2019)

Evaluation of a health system intervention to improve virological management in an antiretroviral programme at a municipal clinic in central Durban
por: Cloete, Christie M., et al.
Publicado: (2019)

Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013)

TB testing in HIV-positive patients prior to antiretroviral treatment
por: Spooner, E., et al.
Publicado: (2022)

Point-of-care HIV testing best practice for early infant diagnosis: an implementation study
por: Spooner, Elizabeth, et al.
Publicado: (2019)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

Getting to under 1% vertical HIV transmission: lessons from a breastfeeding cohort in South Africa
por: Daniels, Brodie, et al.
Publicado: (2022)

Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women
por: Mnqonywa, Nonzwakazi, et al.
Publicado: (2019)

Women and HIV in Sub-Saharan Africa
por: Ramjee, Gita, et al.
Publicado: (2013)

Proportions of CD4+, CD8+ and B cell subsets are not affected by exposure to HIV or to Cotrimoxazole prophylaxis in Malawian HIV-uninfected but exposed children
por: Longwe, Herbert, et al.
Publicado: (2015)

Delayed acquisition of Plasmodium falciparum antigen-specific CD4(+) T cell responses in HIV-exposed uninfected Malawian children receiving daily cotrimoxazole prophylaxis
por: Longwe, Herbert, et al.
Publicado: (2016)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015)

Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa
por: Daniels, Brodie, et al.
Publicado: (2016)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP
por: William, Buwembo, et al.
Publicado: (2012)

High risk sexual behaviors are associated with sexual violence among a cohort of women in Durban, South Africa
por: Gaffoor, Zakir, et al.
Publicado: (2013)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)
por: Parikh, Urvi M., et al.
Publicado: (2013)

Correction: Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)
por: Parikh, Urvi M., et al.
Publicado: (2014)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon
por: Janssen, Saskia, et al.
Publicado: (2015)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*
por: Kasirye, R, et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis Associated With Reduced Anemia Hazard in HIV-Exposed Infants in a Malaria-Endemic Setting
por: Ewing, Alexander, et al.
Publicado: (2017)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Successful treatment of cerebral toxoplasmosis with cotrimoxazole
por: Patil, Harsha V., et al.
Publicado: (2011)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi
por: Everett, Dean B., et al.
Publicado: (2011)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis
por: Juma, Dennis W., et al.
Publicado: (2019)

Facilitators and barriers to cotrimoxazole and nevirapine prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, E, et al.
Publicado: (2012)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014)

Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021)

Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection
por: Boodhram, Resha, et al.
Publicado: (2019)

Iron and the Breastfed Infant
por: Friel, James, et al.
Publicado: (2018)

Manuscript title: Facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, Euphemia L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pbojr4qucq5ng3p6aaqmo36738